BUFFALO, NY -- (MARKET WIRE) -- March 08, 2007 -- Empire Genomics, LLC (EG) announced that it has formed a strategic alliance with BioDiscovery, Inc (BD) to offer complete solutions to the array comparative genomic hybridizations field. Empire’s best in class aCGH services and products will be combined with BioDiscovery’s industry leading proprietary software to reduce the difficulty in obtaining high quality data from assays. EG and BDI will optimize their products to ensure consistency from assay to assay and researcher to researcher. Also as a part of this alliance Empire Genomics and BioDiscovery will co-market and co-promote their products and services to end users.
